Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

BIO Industry Analysis Investor Survey: FDA Approvals Expected to Increase and Majority of Investors Believe Now Is a Good Time to Invest in Biotech

VIEWS: 0 PAGES: 3

WASHINGTON--(EON: Enhanced Online News)--The BIO CEO & Investor Conference wrapped up in NYC yesterday amidst renewed optimism among investors and signs that FDA approvals may be on the rise in 2012, according to BIO Industry Analysis data. img border='0' title='Add to Google' alt

More Info
To top